Mariam Naqshbandi Hayward

Mariam Naqshbandi Hayward

Auto-generated profile, based on publicly available information

Mariam Naqshbandi Hayward

Centre for Studies in Family Medicine, Department of Family Medicine, The University of Western Ontario, London, Ontario, N6G 4X8, Canada

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2012 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
RDRoland F Dyck
Roland F Dyck
MHMariam Naqshbandi Hayward
Mariam Naqshbandi Hayward
SHStewart B Harris
Stewart B Harris
Indigenous peoples worldwide are experiencing elevated rates of type 2 diabetes and its complications. To better understand the disproportionate burden of diabetic end stage renal disease (ESRD) among Canadian First Nations people (FN), we examined prevalence, determinants, and co-morbidities of chronic kidney disease (CKD) within this population.

21 October 2011 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
OBOnil K Bhattacharyya
Onil K Bhattacharyya
IRIrit R Rasooly
Irit R Rasooly
MNMariam Naqshbandi
Mariam Naqshbandi
EEElizabeth A Estey
Elizabeth A Estey
JEJames Esler
James Esler
SHStewart B Harris
Stewart B Harris
Aboriginal peoples globally, and First Nations peoples in Canada particularly, suffer from high rates of type 2 diabetes and related complications compared with the general population. Research into the unique barriers faced by healthcare providers working in on-reserve First Nations communities is essential for developing effective quality improvement strategies.

31 January 2012 in International Journal of Circumpolar Health
Verified
Journal Article
Open access
MHMariamNaqshbandi Hayward
MariamNaqshbandi Hayward
EKElena Kuzmina
Elena Kuzmina
DDDavid Dannenbaum
David Dannenbaum
JTJill Torrie
Jill Torrie
JHJennifer Huynh
Jennifer Huynh
SHStewart Harris
Stewart Harris
Objectives. To evaluate the clinical management of type 2 diabetes in the Eeyou Istchee communities of northern Quebec. Study design. Retrospective quality assurance audit. Methods. Patients with diabetes were identified using the Cree Diabetes Information System. Charts of eligible patients were audited for healthcare visits, glycemic control, blood pressure, lipid profile, pharmacological treatment and complications for the 2006 calendar year. Analyses were performed to assess the association of disease duration, age, target glycemic and blood pressure control with diabetes complications. Results. Half of the patients (49.7%) achieved target HbA1c, 53.6% had a blood pressure of ≤130/80 and 58.7% had an LDL of ≤2.5 mmol/L. The proportion of patients meeting all 3 targets was low at 17.1%. The mean number of diabetes-related clinic visits was high, with an average of 3.9 visits to a physician and an average of 8.7 visits to a registered nurse. Of patients with a documented diabetic complication, 39.4% of patients were not being managed with an ACE/ARB and 48.2% of patients were not prescribed a statin. Conclusions. These findings suggest a possible treatment gap for risk factors and complications management. To circumvent further increases in diabetes-related complications, emphasis should be placed on improved healthcare worker training, greater use of clinical management and patient education tools and improved communication during the diabetes-related clinical visits. Development of a culturally appropriate multidisciplinary approach towards improved understanding of diabetes and multifactorial risk management for diabetic patients is essential for the prevention of diabetic complications.